Envoy Medical, Inc.
COCH · XNASCIK 1840877fmd_0MMJMKAKWWN96QTYNEDV51CHKXManufacturing · Orthopedic, Prosthetic & Surgical Appliances & SuppliesTemplate: Standard
Coverage: Jan 01, 2021 to Sep 30, 2026, 23 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total revenues | – | 0 | 0 | 0 | 0 |
| Cost of revenue | – | 0 | 1 | 1 | 1 |
| Gross profit | – | (0) | (0) | (1) | (1) |
| Research and development | – | 5 | 9 | 10 | 12 |
| Selling, general and administrative | – | 3 | 7 | 9 | 9 |
| Total benefits, losses and expenses | – | – | 0 | – | – |
| Operating income | (5) | (9) | (18) | (19) | (22) |
| Interest expense | – | – | – | 1 | 2 |
| Interest and investment income | 0 | 6 | – | – | – |
| Other non-operating income (expense) | – | (7) | (12) | (2) | (1) |
| Income before taxes | (0) | 21 | – | (21) | (24) |
| Income tax expense | – | 2 | – | – | – |
| Net income from continuing operations | – | 19 | – | – | – |
| Net income | (0) | (16) | (30) | (21) | (24) |
| Net income to common shareholders | – | (16) | (31) | (28) | (29) |